Click Here to download the PDF. Urgent message:Â In December 2022, Congress passed the Mainstreaming Addiction Treatment Act (W-Waiver), which would remove federal patient caps and allow any healthcare provider with a standard DEA controlled-medication license to prescribe buprenorphine. Alan A. Ayers, MBA, MAcc is Senior Editor of The Journal of Urgent Care Medicine and President of Experity Consulting. For over a decade, the question of whether or not to prescribe buprenorphine/naloxone (Suboxone) products in urgent …
Read More